Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

BridgeBio Pharma average net profit margin for 2024 was -223.61%, a 96.05% increase from 2023.
BridgeBio Pharma average net profit margin for 2023 was -5663.72%, a 783.37% decline from 2022.
BridgeBio Pharma average net profit margin for 2022 was -641.15%, a 25.11% increase from 2021.

Net profit margin can be defined as net Income as a portion of total sales revenue.

BridgeBio Pharma Net Profit Margin 2018-2025 | BBIO

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

BridgeBio Pharma average net profit margin for 2024 was -223.61%, a 96.05% increase from 2023.
BridgeBio Pharma average net profit margin for 2023 was -5663.72%, a 783.37% decline from 2022.
BridgeBio Pharma average net profit margin for 2022 was -641.15%, a 25.11% increase from 2021.

Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Teva Pharmaceutical Industries (TEVA)	$15.5B
Dr Reddy's Laboratories (RDY)	$11.4B
Bausch Health Cos (BHC)	$1.9B
Supernus Pharmaceuticals (SUPN)	$1.7B
Amphastar Pharmaceuticals (AMPH)	$1.1B
Personalis (PSNL)	$282M
Taysha Gene Therapies (TSHA)	$254M
Assembly Biosciences (ASMB)	$75M
Sol-Gel Technologies (SLGL)	$15M
Evoke Pharma (EVOK)	$3M
Teligent (TLGT)	$0M